Uniphar PLC Notice of AGM and Annual Report (7152K)
April 24 2020 - 1:00AM
UK Regulatory
TIDMUPR
RNS Number : 7152K
Uniphar PLC
24 April 2020
Publication of Notice of Annual General Meeting and Annual
Report
Dublin, London | 24 April 2020
Uniphar plc (the "Company" or "Uniphar") wishes to announce that
it is today posting to shareholders its Notice of Annual General
Meeting ("AGM") for 2020 together with its annual report and
accounts for the year ended 31 December 2019 ("Annual Report"). The
AGM will be held at 11am on 26 May 2020 at Uniphar's registered
office, 4045 Kingswood Road, Citywest Business Park, Dublin 24, D24
V06K.
Uniphar considers the well-being of shareholders, employees and
attendees a top priority. Based on the latest available guidance
from the Health Service Executive ("HSE") in Ireland, the board of
directors of Uniphar (the "Board") expect the AGM to proceed on 26
May 2020 but under very constrained circumstances.
In line with the measures advised by the HSE and Irish
Governments restrictions on public gatherings, the Board have put
in place a number of measures to minimise the risk of spreading the
Coronavirus (COVID-19) at the AGM and encourage all shareholders,
on this occasion, to refrain from attending the AGM in person and
to complete and return their Proxy Forms as soon as possible to
ensure their vote is registered at the AGM.
Given the severity of the circumstances and the health risks
involved, Uniphar's directors will take all appropriate safety
measures to ensure the safety of attendees and others involved in
the AGM, including restricting attendance at the AGM, should it be
deemed necessary or desirable.
Proxy voting can be carried out in advance of the AGM in one of
the following ways: (1) by completing the Proxy Form enclosed with
the Notice of AGM, (2) via the registrar's website at
www.eproxyappointment.com or (3) via the CREST electronic proxy
appointment service for those shareholders who are CREST
members.
Shareholders may submit questions relating to the business of
the meeting in advance (so as to be received by no later than 5
p.m. on Friday, 22 May 2020) by email to the Company Secretary,
Aisling McCarthy, at amccarthy@uniphar.ie or by post to the
Company's registered office, marked for the attention of the
Company Secretary.
For the convenience and safety of shareholders, the AGM will be
conducted over a live conference call and shareholders may register
to receive participant log-in details at www.directeventreg.com
using the conference ID 7495818. The conference call facility is a
listening facility only and shareholders will not be able to vote
or ask questions via the conference call facility.
The Board encourages shareholders to check Regulatory
Information Services and the Company's website www.uniphar.ie for
any updates in relation to the AGM. Shareholders are also
encouraged to keep up-to-date with Government announcements and to
follow HSE/World Health Organization guidance.
An electronic copy of the Notice of AGM and Annual Report are
available on the Company's website at www.uniphar.ie
--- ENDS ---
For further details contact:
Uniphar +353 (0) 1 428 7777
Brian O'Shaughnessy
Group Director of Corporate Development investor.relations@Uniphar.ie
Davy
(Nominated Adviser and Euronext Growth
Adviser)
Fergal Meegan
Barry Murphy
Tom Tynan +353 (0) 1 679 6363
About Uniphar plc
Headquartered in Dublin, Ireland, Uniphar is an international
diversified healthcare services business servicing the requirements
of more than 200 multinational pharmaceutical and medical
technology manufacturers across three divisions - Commercial &
Clinical, Product Access and Supply Chain & Retail. With a
workforce of more than 2,200, the Group is active in Ireland, the
UK, the Benelux, the Nordics and the US.
The Company's vision is to improve patient access to
pharmaco-medical products and treatments by enhancing connectivity
between manufacturers and healthcare stakeholders. Uniphar
represents a strong combination of scale, growth and
profitability.
Commercial & Clinical
In Commercial & Clinical the Group provides sales, marketing
& distribution solutions to multinational pharmaceutical and
medical device manufacturers on an outsourced basis. Active in
Ireland, the UK, the Benelux and the Nordics, the Group is growing
with clients to provide pan-European solutions. Uniphar have built
a fully integrated multi-channel solution that is supported by
highly experienced, clinically trained teams to deliver exceptional
outcomes for all clients.
Product Access
In Product Access the Group is growing two distinct service
offerings: 1) "On-Demand Access", which are pharmacy led solutions
for sourcing and supplying unlicensed medicines to meet the needs
of both retail and hospital pharmacists; and 2) "Exclusive Access",
which are manufacturer led solutions for controlling the release of
speciality medicines for specifically approved patient populations
in agreed markets. The Group currently delivers product access
solutions to more than 160 markets globally.
Supply Chain & Retail
Uniphar is an established market leader in Ireland with c50%
supply chain market share supported by a network of 287 owned,
franchised and symbol group pharmacies. The business supports the
diverse customer base through the provision of strong service
levels coupled with innovative commercial initiatives. Supply Chain
& Retail is an Irish only business for the Group, although the
assets and infrastructure are utilised for the benefit of the
growth divisions.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NOAKKNBNABKDAQB
(END) Dow Jones Newswires
April 24, 2020 02:00 ET (06:00 GMT)
Uniphar (LSE:UPR)
Historical Stock Chart
From Apr 2024 to May 2024
Uniphar (LSE:UPR)
Historical Stock Chart
From May 2023 to May 2024